PgWellness-Logo

Peripheral Neuropathy Pain Relief

Nervive Nerve Relief and Nerve Relief PM are formulated with 600 mg of ALA to help relieve pain associated with peripheral neuropathy. Results can start in as little as 2 weeks with daily use.

ALPHA-LIPOIC ACID (ALA)

At 600 mg, helps with relief of pain associated with peripheral neuropathy1,2

Nervive Nerve Relief and Nerve Relief PM are formulated with 600 mg of Alpha-Lipoic Acid. Results begin in 14 days with daily use.

THIAMINE (VITAMIN B1)

Contributes to the normal function of the nervous system

Thiamine, or vitamin B1, occurs naturally in foods and is a well-recognized nutrient.

The European Food Safety Authority’s (EFSA) scientific opinion in 2009 established a cause-and-effect relationship between thiamine and its contribution to the normal function of the nervous system.3

MELATONIN

Shown to help regulate sleep cycle4

Melatonin taken once a day (dosage range: 0.1 mg - 10 mg) helps:

  • • Reduce the time it takes to fall asleep
  • • Increase the total sleep time
  • • Regulate the sleep cycle

Nerve Relief PM formulated with 2 mg of melatonin helps patients fall asleep and supports their sleep cycle.

References:

1. Ziegler D et al. Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy: The SYDNEY 2 trial. Diabetes Care 2006:29 (11): 2365–2370. Available at:https://doi.org/10.2337/dc06-1216

2. Nervive Nerve Relief NPN Production Information - https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80114524

3. Scientific opinion. EFSA Journal 2009;7(9):1222.doi:10.2903/j.efsa.2009.1222. Available online: www.efsa.europa.eu

4. Health Canada Melatonin Oral Monograph, August 28, 2018.

WARNINGS

Nerve Relief contains alpha-lipoic acid, therefore consideration should be made in case of concomitant use with other products containing ALA. Other considerations include: if patient is pregnant, breastfeeding or has: diabetes, gallstones, a bile duct obstruction, stomach ulcers, excess stomach acid or other medical condition. Patients should be advised to stop use and consult you if they experience symptoms of serious low blood sugar: sweating, paleness, chills, headache, dizziness and/or confusion. Should not be used if sensitive to any ingredients. Keep out of the reach of children.

Nerve Relief PM should not be used if pregnant or breastfeeding. Insomnia that persists beyond 4 weeks may be chronic and may need further consultation. Advise patient: to avoid taking with alcohol or other products that cause drowsiness, to not drive or use machinery for 5 hours after taking melatonin. Stop use if hypersensitivity or allergy occurs or if the patient experiences headache, confusion or nausea. Contains alpha-lipoic acid, therefore consideration should be made in case of concomitant use with other products containing ALA. Determine the benefits before recommending to patients taking medications for seizure, blood pressure, to suppress the immune system (immunosuppressive medications), to affect mental state or increase sedation, steroids or blood thinners, or to patients who have cardiovascular, immune, liver or chronic kidney disease, hormonal or seizure disorders, asthma, depression, diabetes, low blood sugar, or migraine. Patients should be advised to stop use and consult you they experience symptoms of serious low blood sugar: sweating, paleness, chills, headache, dizziness and/or confusion. Should not be used if sensitive to any ingredients. Keep out of the reach of children.

CONSIDER NERVIVE NERVE RELIEF AND NERVE RELIEF PM FOR PATIENTS EXPERIENCING PAIN ASSOCIATED WITH PERIPHERAL NEUROPATHY

FROM THE WORLD’S #1 SELLING NERVE CARE COMPANY

Nicholas Hall’s global CHC Database, DB6, 2021 value sales at MSP